RxDoctor Payments Data

Shawna Murphy, DO

Emergency Medicine · Center Valley, PANPI 1568678506

Payments from drug & device makers

$225in general payments, 2019–2025

Across 2 payments — averaging $112.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$117
  • AbbVie$109

What the payments were for

  • Food & beverage$225100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson1$117
AbbVie1$109

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$225 in reported general payments places this provider in the 80th percentile of 3,120 emergency medicine providers in Pennsylvania.

See all emergency medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$516,169
Medicare patients
900
Services billed
5,557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban173$85,781
TrulicityDulaglutide28$27,424
XareltoRivaroxaban30$14,876
JardianceEmpagliflozin17$9,057
LinzessLinaclotide14$7,243
FarxigaDapagliflozin Propanediol11$6,349
MyrbetriqMirabegron15$6,119
MovantikNaloxegol Oxalate11$4,845
Cyclosporine11$4,640
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$3,744
Atorvastatin Calcium236$3,481
Gabapentin142$2,808
Metoprolol Succinate157$2,666
Memantine Hcl48$2,444
Potassium Chloride123$2,411

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$117$14,87630 claims
AbbVieLinzess$109$7,24314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,120 emergency medicine providers in Pennsylvania.

Other emergency medicine in Center Valley

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →